You are here

Merck

How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals

Investors Business Daily

Sat, 08/17/19 - 01:31 pm

Which pharmas grew most in Q2? AstraZeneca, Merck and BMS, for 3

Fierce Pharma

Thu, 08/15/19 - 10:42 am

Bristol-Myers Squibb

Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA

Fierce Pharma

Thu, 08/15/19 - 10:39 am

Teva Pharmaceutical

AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment

Pharmaforum

Wed, 08/14/19 - 11:01 am

clinical trials

advanced ovarian cancer

Deploying Experimental Vaccines Against Ebola

Forbes

Fri, 08/9/19 - 10:52 am

MSD’s Keytruda plus chemo backed by NICE for lung cancer

Pharmaforum

Fri, 08/9/19 - 10:30 am

non-small cell lung cancer

Clovis investors feel more Lynparza pressure

EP Vantage

Thu, 08/8/19 - 10:51 am

prostate cancer

Clovis Oncology

AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race

Endpoints

Wed, 08/7/19 - 10:46 am

prostate cancer

clinical trials

These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024

Yahoo/Motley Fool

Sun, 08/4/19 - 01:02 pm

Bristol-Myers Squibb

Merck's spending big to support Gardasil, and the HPV vaccine keeps pumping along

Fierce Pharma

Thu, 08/1/19 - 10:47 am

Just One HPV Dose May Be Enough To Prevent Several Cancers

Forbes

Wed, 07/31/19 - 11:57 pm

cervical cancer

Merck's Keytruda makes the cut as a second-line monotherapy for certain esophageal cancer patients

Endpoints

Wed, 07/31/19 - 10:06 am

esophageal cancer

Sales gap grows between rival Merck, Bristol cancer therapies

Biopharma Dive

Tue, 07/30/19 - 11:33 am

Bristol-Myers Squibb

Merck profit beats on strong demand for Keytruda, vaccines

Yahoo/Reuters

Tue, 07/30/19 - 07:56 am

Merck Data Are Another Step for Immunotherapy in Breast Cancer

Xconomy

Mon, 07/29/19 - 09:32 am

clinical trials

triple negative breast cancer

Cidara posts data from head-to-head trial against Merck antifungal

Fierce Biotech

Mon, 07/29/19 - 09:18 am

clinical trials

Drugmakers will profit from climate change, Morgan Stanley says

Beckers Hospital Review

Sun, 07/28/19 - 11:41 pm

Moderna Therapeutics

Merck Keeps Expansions Rolling with New N.C. Manufacturing Site

BioSpace

Thu, 07/25/19 - 07:08 pm

drug manufacturing

Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck

Xconomy

Wed, 07/24/19 - 10:20 pm

Bristol-Myers Squibb

non-squamous non-small cell lung cancer

FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch

Endpoints

Wed, 07/24/19 - 10:07 am

Samsung Bioepis

Pages